Immunicum AB (publ) (IMMU.ST)
Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
As of 04:08PM CEST. Market open.
Currency in SEK
Valuation measures4
| Market cap (intra-day) | 459.28M |
| Enterprise value | 362.99M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 142.09 |
| Price/book (mrq) | 0.65 |
| Enterprise value/revenue | -232.09 |
| Enterprise value/EBITDA | -2.14 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -59.42% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 1.4700 |
| 52-week low 3 | 0.3000 |
| 50-day moving average 3 | 0.4742 |
| 200-day moving average 3 | 0.4642 |
Share statistics
| Avg vol (3-month) 3 | 1.88M |
| Avg vol (10-day) 3 | 1.46M |
| Shares outstanding 5 | 1.01B |
| Implied shares outstanding 6 | 1.01B |
| Float 8 | 419.77M |
| % held by insiders 1 | 55.33% |
| % held by institutions 1 | 9.59% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,268.57% |
Management effectiveness
| Return on assets (ttm) | -10.04% |
| Return on equity (ttm) | -18.46% |
Income statement
| Revenue (ttm) | 30.98M |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -104.31M |
| Net income avi to common (ttm) | -107.06M |
| Diluted EPS (ttm) | -0.2200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 88.19M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 25.06M |
| Total debt/equity (mrq) | 3.73% |
| Current ratio (mrq) | 7.24 |
| Book value per share (mrq) | 0.75 |
Cash flow statement
| Operating cash flow (ttm) | -159.82M |
| Levered free cash flow (ttm) | -119.26M |
© 2024 Yahoo. All rights reserved.